LINC01359: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01359

NCBI ID: G101927084

LINC01359

Other Name(s): long intergenic non-protein coding RNA 1359 | Long intergenic non-protein coding RNA 1359

LINC01359: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01359 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various organisms, including humans. This RNA has been shown to be involved in a wide range of physiological processes, including cell growth, differentiation, and metabolism. As a result, LINC01359 has potential as a drug target or biomarker.

Drug Target Potential

LINC01359 has been shown to play a role in the regulation of cell proliferation and survival. Several studies have demonstrated that LINC01359 is involved in the cell cycle, with some studies suggesting that it may act as a negative regulator of the G1/S transition. Additionally, LINC01359 has been shown to be involved in the regulation of cell apoptosis, which is a critical aspect of cell growth and development.

Some studies have also suggested that LINC01359 may be a potential drug target for cancer. For example, LINC01359 has been shown to be downregulated in various types of cancer, which may make it an attractive target for therapeutic intervention. Additionally, LINC01359 has been shown to be involved in the regulation of angiogenesis, which is a critical aspect of cancer progression.

Biomarker Potential

In addition to its potential as a drug target, LINC01359 has also been identified as a potential biomarker for various diseases. For example, LINC01359 has been shown to be downregulated in individuals with Alzheimer's disease, which may make it an attractive target for diagnostic or therapeutic intervention. Additionally, LINC01359 has been shown to be involved in the regulation of inflammation, which is a critical aspect of many diseases, including cardiovascular disease and autoimmune disorders.

Conclusion

LINC01359 is a long intergenic non-protein-coding RNA that has been shown to play a critical role in various physiological processes. Its potential as a drug target or biomarker makes it an attractive target for further investigation. Further studies are needed to fully understand the functional roles of LINC01359 in various organisms, including humans. As research continues, LINC01359 may provide new insights into the biology of disease and the potential for therapeutic intervention.

Protein Name: Long Intergenic Non-protein Coding RNA 1359

The "LINC01359 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01359 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets